Lexitas

Lexitas

Ophthalmology-focused CRO for clinical trials

Overview

Lexitas Pharma Services is a clinical research organization focused exclusively on ophthalmology, helping biopharmaceutical and medical device companies advance eye-related products through clinical trials. It provides end-to-end ophthalmic trial services from strategy and protocol design to execution, data management, and analysis. Its niche focus lets it tailor study designs, imaging endpoints, regulatory considerations, and trial operations specifically for eye conditions, unlike generic CROs. Its goal is to help clients bring ophthalmic therapies and devices to market faster with high-quality data to support regulatory approvals and market access.

About Lexitas

Simplify's Rating
Why Lexitas is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Biotechnology

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Durham, North Carolina

Founded

2011

Your Connections

People at Lexitas who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Broader patient access should improve enrollment across retinal disease trials.
  • Element Erie imaging infrastructure strengthens standardized interpretation and trial efficiency.
  • CASExERIE adds surgical training and device evaluation for retina innovation.

What critics are saying

  • Narrow ophthalmology focus limits cross-therapeutic cross-sell versus broader CROs.
  • Retina site and investigator bottlenecks constrain enrollment in competitive indications.
  • Integrated platform execution failure would weaken sponsor confidence and renewal revenue.

What makes Lexitas unique

  • Exclusive ophthalmology CRO with full-stage clinical and medical strategy support.
  • Expanded retina capability via Erie Retina Research, CASExERIE, and Element Erie assets.
  • Integrated ophthalmic device development with NAMSA under a single accountable team.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Seeking Alpha
Feb 14th, 2024
Lexitas appoints Sriram Venkateswaran as CFO

Lexitas appoints Sriram Venkateswaran as CFO.

Global Advertising News
Sep 13th, 2023
Lexitas Pharma Services, Inc. Partners With DiagnosTear Ltd. For The Use Of TeaRx™ In Ophthalmic Clinical Trials

Lexitas Pharma Services, Inc. partners with DiagnosTear Ltd. for the use of TeaRx™ in ophthalmic clinical trials.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Lexitas right now.

Find jobs on Simplify and start your career today

We update Lexitas's jobs every few hours, so check again soon! Browse all jobs →